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background: To develop the ﬁrst international instrument to measure fertility quality of life (FertiQoL) in men and women experien-
cing fertility problems, to evaluate the preliminary psychometric properties of this new tool and to translate FertiQoL into multiple languages.
method: We conducted a survey, both online and in fertility clinics in USA, Australia/New Zealand, Canada and UK. A total of 1414
people with fertility problems participated. The main outcome measure was the FertiQoL tool.
results: FertiQoL consists of 36 items that assess core (24 items) and treatment-related quality of life (QoL) (10 items) and overall life and
physical health (2 items). Cronbach reliability statistics for the Core and Treatment FertiQoL (and subscales) were satisfactory and in the range
of 0.72 and 0.92. Sensitivity analyses showed that FertiQoL detected expected relations between QoL and gender, parity and support-seeking.
FertiQoL was translated into 20 languages by the same translation team with each translation veriﬁed by local bilingual fertility experts.
conclusions: FertiQoL is a reliable measure of the impact of fertility problems and its treatment on QoL. Future research should
establish its use in cross-cultural research and clinical work.
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Introduction
‘Quality of life’ (QoL) was deﬁned by the World Health Organization
(WHO) as an ’...individuals’ perceptions of their position in life in
the context of the culture and value systems in which they live and
in relation to their goals, expectations, standards and concerns...’
(WHOQOL, 1995). The WHOQOL measures QoL broadly accord-
ing to 29 facets (e.g. self-esteem, mobility and safety). QoL measure-
ment is important to identify aspects of fertility problems associated
with poor QoL and advance research in health service-evaluation,
patient satisfaction and policy-making through the use of a standard
measurement tool (Saxena et al., 2001).
Psychosocial studies convincingly demonstrate a high incidence of
negative reactions to infertility and its treatment (Verhaak et al.,
2007) that impact on overall life satisfaction and well-being (Greil,
1997), success of treatment (Boivin and Schmidt, 2005), willingness
to continue with treatment (Smeenk et al., 2004), treatment evalu-
ation (Dancet et al., 2010) and the long-term satisfaction people can
hope to achieve if treatment is unsuccessful and they remain childless
(Daniluk, 2001). Therefore, the need to measure and take into
account QoL in infertility is imperative and tackling this measurement
hurdle could lead to improved patient outcomes.
The 14 existing self-report measures of infertility-speciﬁc distress,
treatment reactions and QoL shown in Supplementary data, Table
S1 do not fulﬁll the need for a fertility speciﬁc QoL assessment tool
(the table includes details of development sample, content and refer-
ence). The fertility problem inventory (FPI: Newton et al., 1999) is the
most frequently used distress measure. However, the items were
developed without consultation with people experiencing fertility pro-
blems and the validation sample comprised primarily Caucasian
patients from a homogeneous socioeconomic category using assisted
reproductive techniques. Further, the FPI assesses level of strain rather
than the broader construct of QoL and does not separate effects due
to infertility treatment from those due to childlessness, which is
important given the emotional challenges of each. These issues
apply to most measures listed in Supplementary data, Table S1. The
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ing from polycystic ovarian syndrome (Cronin et al., 1998). Several
studies have examined its psychometric properties (Jones et al.,
2008) and used it to investigate moderators of QoL (e.g. obesity)
and cross-cultural effects. Results conﬁrm its reliability and the impor-
tance of cultural background as a moderator of QoL (Schmid et al.,
2004; Adamson, 2009). However, this and other quality of life
measures for infertility were designed for speciﬁc sub-populations
(e.g. endometriosis, male factor) and therefore cannot be used as
generic measure for all people with fertility problems.
In summary, the need for a quality of life measure for infertility
measure has not been fully met. Given the importance of addressing
this need, the European Society of Human Reproduction and
Embryology (ESHRE) and the American Society of Reproductive
Medicine (ASRM) joined forces with Merck-Serono
S.A. Geneva-Switzerland (an afﬁliate of Merck KGaA Darmstadt,
Germany) to create the fertility quality of life (FertiQoL) measure
(2002–2009). The overall aim of the FertiQoL project was to
develop an international instrument to measure QoL in men and
women experiencing fertility problems. Secondary aims were to
evaluate the psychometric properties of the tool and to translate
FertiQoL in multiple languages. The development phase was
carried out according to the protocol used for the development
of the WHOQOL measure (WHO, 1998) and is brieﬂy described
in the present article. However, the main focus of this report is
on the psychometric evaluation.
Methods
Participants
Men and women experiencing fertility difﬁculties with and without medical
experience were sampled from one fertility clinic in Australia, Canada,
New Zealand, UK and two clinics from the USA. Patient advocacy web-
sites in these countries (i.e. ACCESS, American Fertility Association,
Resolve, Infertility Awareness Association of Canada, International Consu-
mer Support for Infertility, Infertility Network UK) hosted the online
survey. The clinic sample consisted of 291 women and 75 men, and the
online sample consisted of 1014 women and 34 men. The Ethics Commit-
tee of the School of Psychology, Cardiff University approved the online
study and the Internal Review Board of each clinic approved the clinic
studies.
Materials
The Background Information Form covered socio-demographic status (e.g.
age, education), medical history (e.g. current illness) and fertility-related
characteristics (e.g. duration of infertility).
FertiQoL prototype: The FertiQol items were designed to translate
abstract concepts (e.g. commitment, sense of belonging) into quantitat-
ive items that could collectively indicate the impact of fertility problems
on QoL. Full details of item generation for the prototype are described
in the Supplemental ﬁle and brieﬂy presented here. As shown in Table I,
item-generation involved four stages: generating potential items; eliminat-
ing redundant, irrelevant and outlier items; validation among people with
fertility problems, and cross-cultural survey of acceptability and feasi-
bility. A comprehensive literature review and consultation with psycho-
social infertility experts generated an initial pool of 302 items on
consequences of fertility problems on QoL in the following 14 areas
(e.g. marriage/partnership, social network, emotions, cognitions,
coping, treatment, physical health etc.). The authors classiﬁed the 302
items into three levels of increasing concept speciﬁcity: dimensions
(e.g. interpersonal), domains (e.g. partner relationship) and facets (e.g.
intimacy) to form groups of items tapping into related aspects of
QoL. Classiﬁcation and subsequent focus groups reduced this pool to
102 items, which were submitted to the acceptability and feasibility
study (see Table I). The prototype evaluated in the present study
included these 102 Core items and 27 optional treatment items ident-
iﬁed through the feasibility and acceptability phase.
Translation
FertiQoL was produced in English and translated into 20 languages: Arabic,
Chinese, Croatian,Danish, Dutch, English, Finnish, French,German, Greek,
Hindi, Italian, Portuguese, Romanian, Russian, Serbian, Spanish, Swedish,
Turkish and Vietnamese (see www.fertiqol.org to download FertiQoL;
Korean and Hungarian versions in progress). Cardiff University professional
translators carried out the ﬁrst translation, and two local fertility experts
reviewed it to ensure that it was appropriate to local customs and fertility
word usage. Cross-cultural data will be presented in a separate paper.
Procedure
The items in the prototype FertiQoL survey were randomly presented and
rated on a scale of 0–4, where higher scores indicated more favorable
QoL. The online survey (prototype FertiQoL and Background Information
Form) was designed using SurveyTracker software for Training Technol-
ogies, inc and the paper version for clinic distribution was designed
using InDesign. Webmasters were provided with a hyperlink to the
survey. In clinics, FertiQoL coordinators at each site distributed the
study pack to consecutive patients who returned completed surveys anon-
ymously in a marked collection box in the patient waiting room.
Statistical analysis
Data were screened and duplicate internet protocol (IP) addresses were
eliminatedunlessofdifferentgenderandresponsepattern.Descriptivestat-
istics and correlations were used to identify the best items for each a priori
domain of QoL (e.g. emotional, mind/body, relational and social). This a
priori work was done to ensure that conceptually similar groups of items
were entered into the factor analysis. Factor analyses (orthogonal rotation)
were computed (clinic, online) to ascertain relations among these items.
Items with factor loadings less than 0.30 and eigenvalues less than one
were eliminated. The FertiQoL total and subscale scores were computed
andtransformedtoscaledscoresandsummarystatistics(e.g.reliabilitycoef-
ﬁcient, mean and standard deviation) produced. Scaled scores were com-
puted to achieve a range of 0–100, making comparisons between scales
easier. For scaling, items were reverse-scored (where necessary); all items
then summed and multiplied by 25/k, where k was the number of items
in the desired subscale or total scale. Higher scores mean better QoL.
For the sake of brevity, only ﬁnal analyses are shown here. These analyses
generated the ﬁnal FertiQoL, which composed 24 core items, plus 10
optional treatment items). See www.fertiqol.org for ﬁnal FertiQoL in all
languages and for scoring instructions.
Results
Sample characteristics
Table II shows background characteristics and these show that the
Clinic group were older, and included more men, single women,
same-sex couples and people with a university-education, but
fewer American and UK residents and people living in rural/
FertiQoL psychometric evaluation 2085suburban areas compared with the Online sample. The Clinic
sample was more likely to have at least one child, a shorter dur-
ation of infertility but less likely to have other health problems.
Item analyses
Descriptive and inferential statistics were used to screen for problematic
items. Items were deleted for several reasons [i.e. highly skewed
.............................................................................................................................................................................................
Table I FertiQoL item generation, selection and reduction.
Task and aims Participants Materials Outcome
Literature review and expert
consultation to generate
potential items
Psychosocial experts in reproductive
health (n ¼ 17)
Psychosocial studies 302 items in 14 domains (e.g.
partnership, self-esteem and career)




nurses, clinicians in 11 countries:
Australia, Canada, Denmark, France,





Classiﬁcation and reduction of
item pool to eliminate
redundant or irrelevant items or
rare QoL effects
FertiQoL Technical Working Group
(Boivin, Takefman, Braverman) and
expert panel
WHO selection criteria: items should
be revealing of QoL, cover key
domains, use simple language, ask
about single issues, free of ambiguity,
etc
Item pool reduced to 116 items
WHO response scales matched to items
Focus groups with patients to
validate the items generated by
the experts and uncover any
effects overlooked by the
experts
17 focus groups (n ¼ 136 participants):




(participants) and 116 item-pool
FertiQoL
Item decrease from 116 to 102 (22 items
eliminated and 8 added) based on . or
,50% endorsement
Purposive sampling for age (, or .35
years), gender, duration of infertility (,
or .2 years) and parity (, or .1
child)
Added 18 treatment items; Wording
corrected; eliminated and/or combined
redundant items; improved face validity;
ensured items pertained to QoL and
response scale appropriate
Psychosocial experts facilitated open,
unstructured discussion groups
followed by structured feedback
exercise on FertiQoL item pool;
duration 1.5–2 h
Survey to assess acceptability
and feasibility of FertiQoL item
style in different languages
n ¼ 525 men and women in 10
countries: Argentina (n ¼ 48), Brazil
(n ¼ 96), Canada (n ¼ 59), France
(n ¼ 63), Germany (n ¼ 37), Greece
(n ¼ 32), Italy (n ¼ 47), Mexico
(n ¼ 46), New Zealand (n ¼ 11), Spain
(n ¼ 43), UK (n ¼ 79) and the USA
(n ¼ 43)
102 Core FertiQoL + 27 optional
treatment items
Final Core FertiQol pool for
psychometric phase was 102 items + 27
optional Treatment items
Additional items inquired about
clarity, coverage and problems with
item pool
FertiQoL well accepted, perceived to be
important and timely
Material translated by experts Items easy to understand and relevant
FertiQoL completing 15–20 min
Main problems: items that did not apply
to all people (e.g. single or untreated)
and timeframe for ’Instructions’ required
WHO, World Health Organization; TWG, technical working group (Boivin, Takefman, Braverman). FertiQoL TWG involved in all aspects of project development.
aFocus groups in Singapore cancelled due to the Severe Acute Respiratory Syndrome (SARS) virus.
2086 Boivin et al.distribution,highinter-correlations(of .0.80amongitemset),poorscale
coherence, interpretive issues]. Other items were deleted because they
measured broad constructs (e.g. self-esteem) that could be better cap-
tured by measures designed for that purpose and that, if retained, would





domains. The 10 optional treatment items were conceptualized as
indexing treatment environment and treatment tolerability. An additional
two items measuring satisfaction with QoL and physical health were
retained for the FertiQoL measure to indicate general physical and QoL
satisfaction, but were not included in the factor analysis.
Exploratory factor analyses and internal
consistency
Kaiser-Meyer-Olkin measures of sampling adequacy were .0.80
demonstrating sufﬁcient inter-correlation among items to perform
.............................................................................................................................................................................................
Table II Demographic characteristics of the online and clinic samples
a.
Variable Online (n 5 1048) Clinic (n 5 366) Test statistic (x
2 or t)
Demographic
Age in years mean (SD) 32.9 (4.9) 35.2 (4.0) 7.9
b
Women% (n) 96.8 (1014) 79.5 (291) 113.4
b
Relationship status% (n) 49.4
b
Single 0.2 (3) 4.0 (13)
In stable relationship
Same-sex 1.7 (18) 6.2 (20)
Heterosexual 98.0 (1027) 89.8 (289)
Years in partnership mean (SD)
d 6.85 (3.9) 7.0 (3.9) 0.6




Urban 28.3 (296) 27.1 (95)
Suburban 55.8 (584) 69.5 (244)
Rural 15.9 (166) 3.4 (12)
Country% (n) 243.4
b
Australia/NZ 14.5 (152) 25.1 (92)
Canada 10.3 (108) 42.0 (154)
UK 8.7 (91) 2.7 (10)
USA 64.1 (672) 30.2 (111)
Other 2.4 (25) —
Reproductive characteristics
Parenthood % (n) 18.9 (197) 30.1 (108) 19.8
b
Years infertile mean (SD) 3.4 (2.9) 2.9 (2.0) 2.4
c
Know why infertile,% (n) 75.4 (790 70.3 (225) 3.3
Perceived diagnosis % (n) 82.4
b
Unexplained 10.9 (86) 14.0 (38)
Female factor 44.5 (351) 18.0 (49)
Male factor 19.9 (157) 21.7 (59)
Mixed 11.9 (94) 14.7 (40)
Same-sex 1.6 (13) 3.3 (9)
Age-related 4.1 (32) 8.8 (24)
Other 7.1 (56) 19.5 (53)
Other health problems% (n) 30.8 (309) 24.0 (260) 5.8
c
Years treated mean (SD) 2.03 (2.4) 2.43 (1.8) 1.6
A total of 491 people did not provide data years of treatment due to no treatment experience or missing data.
aSample size varies per variable.
bP , 0.001.
cP , 0.05.
dFor people in partnerships.
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Table III Factor loadings for online and clinic (in parenthesis) samples on FertiQoL items.
Core FertiQoL Optional Treatment FertiQoL module







Fluctuate hope/despair 0.643 (0.759)
Jealousy and resentment 0.737 (0.634)
Unable to cope 0.640 (0.594)
Affectionate 0.749 (0.732)
Difﬁcult to talk 0.629 (0.696)
Negative impact on relationship 0.707 (0.633)
Content relationship 0.768 (0.616)
Strengthen relationship 0.713 (0.603)











Family understand 0.669 (0.669)
Friend support 0.751 (0.649)















Interactions with staff 0.813 (0.784)
Quality treatment information 0.802 (0.784)
Quality surgery and medical
treatment
0.780 (0.763)
Fertility staff understand us 0.728 (0.750)
Quality emotional services 0.632 (0.664)
Medical services desired available 0.576 (0.585)
Bothered effect daily activities and
work
0.799 (0.790)




Treatment effects on mood 0.645 (0.681)
Online eigenvalue (% variance) 7.62 (31.8) 2.61 (10.9) 1.44 (6.0) 1.16 (4.8) 3.48 (34.9) 1.92 (19.3)
Clinic eigenvalue (% variance) 8.93 (37.8) 2.37 (9.9) 1.23 (5.1) 1.08 (4.5) 3.80 (38.0) 1.68 (16.8)
Bold indicates ﬁrst item of each domain.
Some items reversed to avoid negative loadings. See www.fertiqol.org for ﬁnal FertiQoL item wording, response scale wording and downloads in 20 languages. Only factor loadings
.0.30 are shown. Factor loadings for Clinic sample in parenthesis.
aIndicates a cross-loadings.
bWording for these items changed as a result of psychometric evaluation and participant feedback.
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parenthesis) Clinic samples for the Core FertiQoL and Optional
Treatment Module domains. The ﬁrst factor explaining item variance
in the Core FertiQoL was the Emotional subscale explaining 31.8%
(Online) and 37.8% (Clinic) of the item variability. Other factors
(mind/body, relational and social) explained 10% or less of the item
variance but all eigenvalues were above one. Loadings showed that
items conceptualized to tap into the same concepts all had high
factor loadings (.0.30) on their designated factor. Cross-loadings
were observed for items of the mind/body (i.e. concentration, life
on hold) and social domains (i.e. isolation, shame) onto the emotional
domains. For the Optional Treatment Module, the ﬁrst factor was
Treatment Environment, explaining 34.0% (Online) and 38.0%
(Clinic) of item variance. There were no cross-loadings for the Treat-
ment Quality and Treatment Tolerability subscales. Table IV shows
summary information for all FertiQoL scales. Core FertiQoL and
Treatment FertiQoL were normally distributed and individual sub-
scales were normally distributed (data not shown), with only the rela-
tional subscale showing mild positive skew toward more favorable
QoL in this domain.
Sensitivity analyses for sub-scales and total
scores
Potential moderators of QoL (gender, parenthood status and recruit-
ment source) were examined in relation to FertiQoL scores. Women
had a signiﬁcantly lower Core FertiQoL (M ¼ 53.3, SD ¼ 16.2) than
did men (M ¼ 72.1, SD ¼ 14.7) (t(1224) ¼ 10.3, P , 0.001). Core
FertiQoL was signiﬁcantly lower for participants without children
(M ¼ 53.3, SD ¼ 16.3) than participants with children (M ¼ 59.5,
SD ¼ 17.7) (t(1217) ¼ 5.27, P , 0.001). Participants recruited from
the online patient advocacy and support sites had signiﬁcantly lower
scores (M ¼ 50.7, SD ¼ 15.1) than did participants recruited from
clinics (M ¼ 67.8, SD ¼ 15.6) (t(1224) ¼ 16.6, P , 0.001).
The relationship between treatment subscales and six treatment
persistence items (e.g. likelihood of trying further treatment, couple
agreeing to persist, thinking of ending treatment) was also examined.
Greater intention to persist with treatment was signiﬁcantly associated
with better Treatment FertiQoL (r(1026) ¼ 0.172, P , 0.001),
especially in the Clinic sample (r(206) ¼ 0.289, P ,0.001).
Discussion
It is currently accepted that to effectively measure the impact of
disease, one needs a disease-speciﬁc instrument (WHOQOL,
1995). FertiQol is a reliable and sensitive measurement tool for
QoL in individuals with fertility problems. More than 2000 people
with fertility problems contributed to the creation of FertiQoL, and
it was developed using an integrated mixed-method approach that
included literature reviews, international expert consultations,
patient focus groups, a cross-cultural feasibility and acceptability
survey, and a psychometric survey evaluation. FertiQoL comprises
of a Core module evaluating the impact of fertility problems on
emotional, mind-body, relational and social domains and an optional
Treatment module evaluating treatment environment and tolerability.
Subscales and total scales show mainly high reliability and sensitivity of
FertiQoL to well-established moderators of QoL. FertiQoL is available
in 20 languages with more translations in progress. This project was
fully realized as a result of collaboration among ESHRE, ASRM and
Merck S.A. Geneva-Switzerland (an afﬁliate of Merck KGaA Darm-
stadt, Germany). It is expected that FertiQoL will signiﬁcantly
.............................................................................................................................................................................................
Table IV Means and standard deviations for FertiQoL subscales and total scaled scores for the validation sample
(online, clinic combined).







Emotional 1349 Impact on emotions (e.g. causes sadness, resentment, grief) 6 0.90 45.10 (23.2)
Mind-body 1338 Impact on physical health (e.g. fatigue, pain), cognition (e.g. poor
concentration) and behavior (e.g. disrupted daily activities)
6 0.84 54.86 (21.2)
Relational 1330 Impact on partnership (e.g. sexuality, communication and
commitment)
6 0.80 68.70 (19.2)
Social 1343 Impact on social aspects (e.g. social inclusion, expectations and
support)
6 0.75 51.10 (20.6)
Core FertiQoL 1226 Average quality of life in all core domains 24 0.92 54.60 (16.8)
Treatment subscales
Environment 1072 Impacts related to treatment environment (e.g. access, quality,
interactions with staff)
6 0.84 61.53 (19.6)
Treatment
tolerability
1093 Impacts due to consequences of treatment (e.g. physical and mode
effects, daily disruptions)
4 0.72 58.81 (20.6)
Treatment
FertiQoL
1043 Average quality of life for all treatment domains 10 0.81 60.43 (16.2)
Total FertiQoL 930 Average quality of life for all core and treatment domains 34 0.92 55.43 (14.8)
All items reversed or scored so that higher scores indicate more favorable QoL. Core FertiQoL refers to see www.fertiqol.org for ﬁnal FertiQoL items, response scale wording and
downloads in 20 languages. Bold refers to total scores.
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gating and ultimately improving QoL in people with fertility problems.
Certain methodological limitations need to be taken into account.
First, despite the multi-disciplinary contributions from experts world-
wide, focus groups and a feasibility and acceptability study in 10
countries, the ﬁnal psychometric evaluation only occurred in ﬁve
English-speaking countries. Second, targeted efforts to recruit a
diverse group of people were not entirely successful in recruiting par-
ticular subgroups (i.e. secondary infertile, men). Indeed, more psycho-
metric research on men is required to fully establish reliability and
validity. Third, the major proportion of the ﬁnal sample was recruited
online, and differences between the Online and Clinic sample were
observed. Although, data generated online have been shown to be
as valid as data collected through traditional methods (Bunting and
Boivin, 2007; Lieberman, 2008), one would need to determine
whether the differences observed warrant a more in-depth
analysis—for example, a different set of norms for clinic samples.
We eliminated records coming from the same IP address but it may
be possible that the same person replied more than once to the
survey. Finally, the subscales of the Core FertiQoL were not entirely
orthogonal with cross-loadings on the social and mind/body
domains. While these associations are expected, we have now modi-
ﬁed the ﬁnal wording of four FertiQoL items to reduce these cross-
loadings. Further evaluation of these changes and FertiQoL as a
whole on a new sample is required for ﬁnal validation. These main
limitations should be addressed in future psychometric research eval-
uating FertiQoL. However, the strengths of our mixed-method
approach, and consultation and evaluation from infertile people
ensure that FertiQoL captures the key life domains affected by fertility
problems. It is hoped that FertiQoL will become a gold standard for
the measurement of QoL for individuals experiencing fertility
problems (whether in treatment or not).
FertiQol will be useful to clinicians and researchers alike. FertiQoL can
be used to identify people at risk of impaired QoL so that psychosocial
resources can be offered and subscale scores could identify the speciﬁc
domains where intervention might be most beneﬁcial. Recent research
has shown a close correspondence between Core FertiQoL and stan-
dardized measures of anxiety and depression in a Dutch sample
(Aarts et al., 2011). The availability of FertiQoL in 20 languages will facili-
tate essential cross-cultural research, particularly in developing nations
(Ombelet et al., 2008; van Balen and Bos, 2010). However, whether
cross-cultural differences exist, whether different populations have differ-
ent mean scores and whether separate cultural norms are needed are all
important questions that need to be addressed in future research.
A unique aspect of FertiQoL compared with other QoL measures is
the optional 10-item treatment module. This module measures QoL
in respect of treatment quality (interactions with staff, quality of infor-
mation), and treatment tolerability (effects on mood, disruptions daily
life). These subscales can be used to assess effectiveness of new treat-
ments/medications, to monitor quality of services and to optimize
patient treatment experiences. Research has shown that quality of
treatment and its tolerability are predictors of treatment satisfaction
(Dancet et al., 2010) and willingness to persist with treatment
(Olivius et al., 2004), the latter also shown in the present study.
Further a recent large, multi-centered study showed a strong associ-
ation between a high level of patient-centered care and favorable Fer-
tiQoL scores (Aarts et al., 2010). However, the sensitivity of
Treatment FertiQoL for these purposes needs to be investigated in
clinical trials of new interventions.
In conclusion, the overall aim of the FertiQoL project was to
develop an international instrument to measure QoL in men and
women experiencing fertility problems, with the collaboration of indi-
viduals experiencing fertility problems and international experts in the
ﬁeld. This objective was accomplished and future use of FertiQoL will
be essential to establish FertiQoL as an essential measurement tool
for practice, research, health service-evaluation and policy-making.
Supplementary data
Supplementary data are available at http://humrep.oxfordjournals.org/.
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